Found some more recent news on STLT Biotech with only 9.9 Mil shares in the OS. But we had missed this news, till just now IIRC? https://www.healthcaretechoutlook.com/news/celtic-biotech-iowa-licenses-a-propitious-therapy-for-acute-and-chronic-nephropathy-nid-39.html Going to try an find someone that knows what is going on.